In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae

被引：58

作者：

Barry, AL ^{[1
]}

Fuchs, PC ^{[1
]}

Brown, SD ^{[1
]}

机构：

[1] Inst Clin Microbiol, Wilsonville, OR 97070 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1998年 / 42卷 / 08期

关键词：

D O I：

10.1128/AAC.42.8.2138

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The ketolide HMR 3647 (previously RU 66647) was evaluated against 2,563 recent clinical isolates of gram-positive pathogens and 200 Haemophilus influenzae isolates. HMR 3647 was active against macrolide-resistant streptococci, including pneumococci, but was not active against macrolide- or lincosamide-resistant staphylococci. Against H. influenzae, the potency of HMR 3647 was similar to that of azithromycin.

引用

下载

页码：2138 / 2140

页数：3

共 50 条

[1] In-vitro activity of the new ketolide antibiotic HMR 3647 against Gram-positive bacteria
Schülin, T
Wennersten, CB
Moellering, RC
Eliopoulos, GM
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (03) : 297 - 301
[2] In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria
Malathum, K
Coque, TM
Singh, KV
Murray, BE
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) : 930 - 936
[3] The bactericidal activities of HMR 3004, HMR 3647 and erythromycin against Gram-positive bacilli and development of resistance
Fernández-Roblas, R
Calvo, R
Esteban, J
Bryskier, A
Soriano, F
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (02) : 285 - 289
[4] Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against Gram-positive cocci of known erythromycin susceptibility status
Hamilton-Miller, JMT
Shah, S
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (06) : 649 - 653
[5] In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against coryneform bacteria
Martínez-Martínez, L
Pascual, A
Suárez, AI
Perea, EJ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) : 3290 - 3292
[6] Comparative in vitro activity of telithromycin (HMR 3647), three macrolides, amoxycillin, cefdinir and levofloxacin against Gram-positive clinical isolates in Japan
Okamoto, H
Miyazaki, S
Tateda, K
Ishii, Y
Yamaguchi, K
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (05) : 797 - 802
[7] In vitro activities of a new lipopeptide, HMR 1043, against susceptible and resistant gram-positive isolates
Bemer, P
Juvin, ME
Bryskier, A
Drugeon, H
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) : 3025 - 3029
[8] In vitro activities of ketolide HMR3647, macrolides, and other antibiotics against Lactobacillus, Leuconostoc, and Pediococcus isolates
Zarazaga, M
Sáenz, Y
Portillo, A
Tenorio, C
Ruiz-Larrea, F
Del Campo, R
Baquero, F
Torres, C
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (12) : 3039 - 3041
[9] In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany
Reinert, RR
Bryskier, A
Lütticken, R
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (06) : 1509 - 1511
[10] In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
Hoban, DJ
Zhanel, GG
Karlowsky, JA
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 35 (01) : 37 - 44

← 1 2 3 4 5 →